Immediate versus modified release hydrocortisone in mitotane-treated patients with adrenocortical cancer.

about

Role of Mitotane in Adrenocortical Carcinoma - Review and State of the art

P2860

Q57822726-B956578F-E9A2-4CCE-A329-B0588BA1EB09

P2860

Immediate versus modified release hydrocortisone in mitotane-treated patients with adrenocortical cancer.

Item

http://www.wikidata.org/entity/Q51210622

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Immediate versus modified rele ...... ts with adrenocortical cancer.

@en

Immediate versus modified rele ...... ts with adrenocortical cancer.

@en-gb

Immediate versus modified rele ...... ts with adrenocortical cancer.

@nl

type

Item

label

Immediate versus modified rele ...... ts with adrenocortical cancer.

@en

Immediate versus modified rele ...... ts with adrenocortical cancer.

@en-gb

Immediate versus modified rele ...... ts with adrenocortical cancer.

@nl

prefLabel

Immediate versus modified rele ...... ts with adrenocortical cancer.

@en

Immediate versus modified rele ...... ts with adrenocortical cancer.

@en-gb

Immediate versus modified rele ...... ts with adrenocortical cancer.

@nl

P1154

2-s2.0-85012070624

http://www.w3.org/2001/XMLSchema#string

P1433

Clinical Endocrinology

P1476

Immediate versus modified rele ...... ts with adrenocortical cancer.

@en

P2093

Amar Agha

http://www.w3.org/2001/XMLSchema#string

Daniela Beier

http://www.w3.org/2001/XMLSchema#string

Kathrin Frey

http://www.w3.org/2001/XMLSchema#string

Kathrin Zopf

http://www.w3.org/2001/XMLSchema#string

Lucy Ann Behan

http://www.w3.org/2001/XMLSchema#string

Marianne Weigel

http://www.w3.org/2001/XMLSchema#string

Mark Sherlock

http://www.w3.org/2001/XMLSchema#string

Wiebke Arlt

http://www.w3.org/2001/XMLSchema#string

P2860

Adjuvant mitotane treatment for adrenocortical carcinoma

Cross-reactivity of steroid hormone immunoassays: clinical significance and two-dimensional molecular similarity prediction

Optimizing glucocorticoid replacement therapy in severely adrenocorticotropin-deficient hypopituitary male patients.

Clinical review: Adrenocortical carcinoma: clinical update.

Hepatic microsomal enzyme induction and adrenal crisis due to o,p'DDD therapy for metastatic adrenocortical carcinoma.

Optimal treatment of adrenocortical carcinoma with mitotane: results in a consecutive series of 96 patients.

Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors

Long-acting hydrocortisone for glucocorticoid replacement therapy.

Drug interactions with mitotane by induction of CYP3A4 metabolism in the clinical management of adrenocortical carcinoma.

Adrenocortical carcinoma: past, present, and future.

P304

499-505

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CEN.13302

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Stefanie Hahner

Paul Stewart

Marcus Quinkler

P577

2017-01-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6366

2569233656

http://www.w3.org/2001/XMLSchema#string

P698

28063163

http://www.w3.org/2001/XMLSchema#string